Articles

This blog installment looks at the use of cannabis for pets. Topics covered include the history of cannabis use in veterinary medicine, current laws on cannabis for pets, market size and segment, reported experiences from both pet owners and veterinarians, and pet toxicology. 

Overview of Cannabis for Pets

Brandy Young, PhD, the CEO and Founder of Certainty Analytical Labs in New York, discussed her work in compliance testing for cannabis products at EAS 2023.

EAS Live Coverage: The Characterization of D9-THC

Videos

Brandy Young, PhD, an analytical chemist with more than 15 years of experience, entered the cannabis industry in response to a recognized need for laboratory testing, aligning her expertise with the emerging demand in New York's active medical and adult-use cannabis programs. Here, she shares some background information on her talk at the Eastern Analytical Symposium (EAS), which delves into the characterization of tetrahydrocannabinol (THC) isomers in cannabis products.

Analyzing THC Isomers in Cannabis: An EAS Interview with Brandy Young

Whether someone is struggling with acute or chronic pain, cannabis can be a powerful tool as an alternative or adjunct treatment.

How Can Cannabis Be a Path from Pain toward Restored Function?

The webinar “Cannabis and Dementia: Unlocking the Potential” was held on June 14, 2023, and featured four panelists’ experiences treating dementia symptoms with cannabis.

Cannabinoids Are Key: Highlights from a Webinar on Treating Dementia with Cannabis

One recently published study suggests that a cannabis sublingual spray may be beneficial in the treatment of type 2 diabetes.

The Effects of a Sublingual Cannabis Spray on Patients with Type 2 Diabetes

A civil lawsuit filed in Arkansas by a medical cannabis patient alleges that three cannabis growers and one testing laboratory inflated the amount of tetrahydrocannabinol (THC) in numerous cannabis products.

Civil Lawsuit Accuses Arkansas' Largest Cannabis Testing Laboratory of Conspiring with Cultivators to Inflate THC Levels

One of the recurring challenges in the medical cannabis space is the difficulty in conducting research because of the plant’s Schedule I status. Although there are some researchers diving in with special licenses to conduct clinical studies, there are others that are looking at real-world users to supply data. For instance, Dr. Daniel J. Kruger is a Research Investigator with the Population Study Center at the University of Michigan and Principal Investigator on a study being conducted with the Releaf app. Here, Dr. Kruger shares his interest and background in these types of surveys and his plans for the current study with Releaf on chronic pain.